The Oregon Senate voted 26-1 to pass SB 1571, redefining "tobacco products" in state law to include nicotine pouches — closing a regulatory loophole that allowed products like Zyn to be sold to minors. Sponsored by Sen. Lisa Reynolds, D-Portland, a pediatrician, the bill ensures that synthetic nicotine products face the same under-21 sales restrictions, retailer licensing requirements, and tax treatment as traditional tobacco products.

The nicotine pouch market has exploded nationally — Zyn alone saw over $3 billion in U.S. sales in 2025 — and Oregon's existing statutory definitions, written before these products existed, created an enforcement gap. Because nicotine pouches contain no tobacco leaf, they technically fell outside Oregon's tobacco product regulations. Retailers could sell them without tobacco retailer licenses, and the under-21 age verification requirements that apply to cigarettes and vaping products did not clearly extend to pouches. SB 1571 eliminates that ambiguity with near-unanimous legislative support.

Oregon healthcare providers — especially pediatricians, dentists, and school-based health center staff — should welcome this change as a regulatory tool that supports clinical messaging. Nicotine pouches carry oral health implications including gum recession, mucosal irritation, and nicotine dependence that complicates orthodontic and periodontal treatment. Dental hygienists performing oral assessments on adolescents should be screening for pouch use alongside vaping and smokeless tobacco. Behavioral health providers treating adolescent substance use should incorporate nicotine pouch awareness into their assessment protocols. Sen. Reynolds' dual role as legislator and pediatrician lends clinical credibility to the bill that providers can reference in patient education.

Watch for House passage, the Governor's signature, and whether Oregon Health Authority updates its tobacco prevention programs to explicitly include nicotine pouches.